PharmaSynergy Autumn 2021

The event showcases pharma opportunities for internationalisation, in/out-licensing, investment and portfolio development.

PharmaSynergy -Autumn will take place on 22-23rd September 2021, Berlin & online

The event is built around 1-2-1 meetings that connect global pharma BD & Licensing professionals together, empowered further by the content-driven programme. Whether you join us to understand where the generics industry is heading, to learn about BD opportunities in #pharmerging and #mature markets or to arrange for the #partnering_meetings with new and established BD peers – #PharmaSynergy is your go-to event for #Business_Development & Licensing.


Speakers Include


Juliana Mazza Reis, Global Director, Business Development and M&A, ACINO


Mayank Mathuriya, Vice President, Head of Business Development, Menarini Asia-Pacific


João Ribeiro, Head of Medical Business, Chanelle Pharma


Antonio Nardi, Vice President, Business & Portfolio Development, Italfarmaco


Olivier Reinhard, Head of Business Development, Emerging Markets EPD, Abbott


Helio Marcelo Segouras, Consumer Health Division Head, Hypera Pharmaceuticals


Marianne Hundtofte Nielsen
Vice President Business Development Europe & Medical Director, Aurora Europe


Can Adamoglu, Head of Commercial Operations, Regulated Markets & Licensing, Abdi Ibrahim Pharmaceuticals


Fabian Riess, Senior Director Business Development & Strategy, Consumer Selfcare International, Perrigo


Ekrem Turajlić, Regional Director for Middle East, Africa, and Turkey, Bosnalijek


Franziska Katterbach, President Europe, Khiron Life Sciences


Keith Strachan, CEO, MediPharm Labs 


Jennifer Wang, Business Development, Alibaba Group


Lisa Haag, CEO, MJ Universe


Thomas Heil, Vice President, Consumer Health, IQVIA


Thomas Haffner, Managing Partner & Founder, THAFF Healthcare Consulting

Ridvan Karacagil, Head of Business Development MEA, Sandoz/Novartis

Agenda Highlights

With so many therapeutic peculiarities, inherited portfolios and strategic directions, PharmaSynergy attendees represent an infinite selection of business strategies. The autumn edition conference agenda will look in detail at just some of these strategies for competitive growth.

Internationalization and competitive growth 

  • Internalization via effective licensing strategy
  • Assets acquisitions in different Geos
  • Development of the go-to-market strategy based on the portfolio strength
  • Portfolio development for sustaining competitive growth

Focus day on OTC

  • The current opportunities in consumer health and OTC products for the Latin American market
  • Assessing the pandemic’s impact on companies’ portfolios and BD&L strategies
  • The Opportunities for OTC brands in China

Cannabis Spotlight

  • The cannabis market: an overview of the key regulatory developments and opportunities in Europe
  • Strategic partnerships in the cannabis market

Who will you meet?

Speaker Ads PharmaSynergy Autumn 2021

What to expect from 1-2-1 partnering?

A truly international B2B platform: the event offers a partnering opportunity with key players from Europe, Africa, LATAM, CIS, SEA and MENA.

PharmaSynergy by Title 2021

With 15% of CEOs / Managing Directors,  47% of Senior Vice Presidents / Heads of Business Development, and 38% of BD Managers your conversations convert into business opportunities.



A broad-spectrum of product portfolios for both In & Out-Licensing conversations. Whether it is “live or digital”, a carefully composed profile-matching mechanism based on key sector-driven criteria allows for efficient and targeted partnering meetings.

The venue

Venue: HOTEL BRISTOL BERLIN (clickable link). Please quote PharmaSynergy as a Promotion Code.

* Subject to local Covid-19 regulation.

* Face-to-Face requirements: all participants planning to travel to Berlin for a face-to-face event are required to present a daily negative COVID-19 test OR need to prove a full course of the COVID-19 vaccine. A second dose must be administered at least 14 days prior to your travel to the PharmaSynergy.

What is a HYBRID event? 

The freedom to choose how you want to connect with your potential partners and event speakers.

The event will take place in a Hybrid format: the attendees can join LIVE* or via Event Platform.

The Digital Platform will be open for two weeks before and two weeks after the LIVE edition to enable all delegates to connect for 1-2-1 meetings and to offer those who opted to attend digitally to watch the content-filled two days of presentations and panel discussions online.

What do our attendees think about PharmaSynergy?

This PharmaSynergy edition was exceptional, I have just finished my scheduled meetings, and have lots of excellent leads, creative ideas and relations with wonderful industry colleagues, more than I have expected and had in previous editions.

– SAJA Pharmaceuticals (Saudi Arabia)

Very good overview of the Emerging Markets

- International Marketing and Business Development Manager, Protina Pharmazeutische GMBH (Germany)

It was a great event, congratulations! There were fantastic companies attending and very interesting speakers.


– Reig Jofre (Spain)